Wellmarker Bio
PrivateLast Round
Series C
Aug 1, 2021
Est. Valuation
$170M
Total Funding Raised
$61.55M
Company Overview
Wellmarker Bio operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series C round in August 2021.
Wellmarker Bio is a biopharmaceutical company that develops first-in-class anticancer drugs based on predictive biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wellmarker Bio Comparables
Compare Wellmarker Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ABL Bio, Inc. | 76% | |
| MedPacto, Inc. | 76% | |
| SCBIO | 74% |
For institutional investors. Book with your work email.
Wellmarker Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 1, 2021 | ||||
| Series B | Jul 8, 2019 | ||||
| Series A | Nov 8, 2018 | ||||
| Seed | Apr 1, 2018 | ||||
| Corporate Funding | Dec 27, 2016 |
For institutional investors. Book with your work email.
Wellmarker Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seoul Investment Partners | Series C |
| The Wells Investment | Series A |
| Meritz Securities Co., Ltd. | Series A |
| Friend Investment Partners | Series A |
| GAIA Venture Partners | Series A |
| Sun & Tree Asset Management | Series B |
| NH Investment & Securities | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 2678% MoM, from 72 to 2K.
- Aug 1, 2021
$12M round with participation from GTOG Private Equity and others.
For institutional investors. Book with your work email.
Wellmarker Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wellmarker Bio's valuation, stock price, and market status.
Is Wellmarker Bio a public or private company?
Wellmarker Bio is a private company.
What is the current stock price of Wellmarker Bio?
Wellmarker Bio is a private company, so its shares have no public market price. Caplight tracks Wellmarker Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wellmarker Bio worth (valuation)?
Wellmarker Bio's valuation is estimated at $170.0M based on funding round data.
Can I buy Wellmarker Bio stock?
Wellmarker Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wellmarker Bio's last funding round?
Wellmarker Bio's most recent funding round was Series C on August 1, 2021.
Who are the main investors in Wellmarker Bio?
Key investors in Wellmarker Bio include Seoul Investment Partners, The Wells Investment, Meritz Securities Co., Ltd., Friend Investment Partners, GAIA Venture Partners.
Will Wellmarker Bio IPO soon?
No public IPO plans have been announced for Wellmarker Bio.
How can I track Wellmarker Bio secondary market activity?
Caplight tracks bids, offers, and trades in Wellmarker Bio's shares on secondary markets.